Screening and Management of Depression in Patients With Cardiovascular Disease: JACC State-of-the-Art Review
Depression is a common problem in patients with cardiovascular disease (CVD) and is
associated with increased mortality, excess disability, greater health care expenditures, and …
associated with increased mortality, excess disability, greater health care expenditures, and …
Combining antidepressants vs antidepressant monotherapy for treatment of patients with acute depression: a systematic review and meta-analysis
J Henssler, D Alexander, G Schwarzer, T Bschor… - JAMA …, 2022 - jamanetwork.com
Importance Combining antidepressants is frequently done in the treatment of acute
depression, but studies have yielded conflicting results. Objective To conduct a systematic …
depression, but studies have yielded conflicting results. Objective To conduct a systematic …
Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III): a single-blind, parallel-group, randomised …
Background The effectiveness of the COVID-19 vaccination programme depends on mass
participation: the greater the number of people vaccinated, the less risk to the population …
participation: the greater the number of people vaccinated, the less risk to the population …
Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions
Treatment‐resistant depression (TRD) is common and associated with multiple serious
public health implications. A consensus definition of TRD with demonstrated predictive utility …
public health implications. A consensus definition of TRD with demonstrated predictive utility …
[HTML][HTML] Antidepressant augmentation versus switch in treatment-resistant geriatric depression
EJ Lenze, BH Mulsant, SP Roose… - … England Journal of …, 2023 - Mass Medical Soc
Background The benefits and risks of augmenting or switching antidepressants in older
adults with treatment-resistant depression have not been extensively studied. Methods We …
adults with treatment-resistant depression have not been extensively studied. Methods We …
Pharmacological treatments for patients with treatment-resistant depression
VL Ruberto, MK Jha, JW Murrough - Pharmaceuticals, 2020 - mdpi.com
Over a third of patients with major depressive disorder (MDD) do not have an adequate
response to first-line antidepressant treatments, ie, they have treatment-resistant depression …
response to first-line antidepressant treatments, ie, they have treatment-resistant depression …
Effect of repetitive transcranial magnetic stimulation on treatment-resistant major depression in US veterans: a randomized clinical trial
JA Yesavage, JK Fairchild, Z Mi, K Biswas… - JAMA …, 2018 - jamanetwork.com
Importance Treatment-resistant major depression (TRMD) in veterans is a major clinical
challenge given the high risk for suicidality in these patients. Repetitive transcranial …
challenge given the high risk for suicidality in these patients. Repetitive transcranial …
Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression
F Scott, E Hampsey… - Journal of …, 2023 - journals.sagepub.com
Background: Major depressive disorder (MDD) is a highly burdensome health condition, for
which there are numerous accepted pharmacological and psychological interventions …
which there are numerous accepted pharmacological and psychological interventions …
Pharmacotherapies for treatment-resistant depression: how antipsychotics fit in the rapidly evolving therapeutic landscape
One in three adults with major depressive disorder (MDD) do not experience clinically
significant improvement after multiple sequential courses of antidepressants and have …
significant improvement after multiple sequential courses of antidepressants and have …
The cardiovascular effects of newer antidepressants in older adults and those with or at high risk for cardiovascular diseases
LM Behlke, EJ Lenze, RM Carney - CNS drugs, 2020 - Springer
Depression is common in older adults and those with cardiovascular disease. Although
selective serotonin reuptake inhibitors generally have been shown to be safe to treat …
selective serotonin reuptake inhibitors generally have been shown to be safe to treat …